Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD

Blood (2019) 134 (Supplement_1): 5647.

https://doi.org/10.1182/blood-2019-125275

Published: 2019

Journal Articles

Novel MEIS1-FOXO1 Fusion Gene in a Case of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Chuang Jiang, PhD, Jiabi Qian, M.Sc, Wenge Hao, MD, Wei LIU, MD, Shuhong Shen, MD PhD, Hua Jiang, MD, Hui Zhang, PhD

Blood (2018) 132 (Supplement 1): 5283.

https://doi.org/10.1182/blood-2018-99-116354

Published: 2018

Journal Articles

A Novel Hierarchical Prognostic Model Based on Clinical Feature and Cytogenetics for Splenic Marginal Zone Lymphoma

Yuting Yan, Wenjie Xiong, Shuhua Yi, MD, PhD, Rui Lv, MD, PhD, Zhen Yu, Wei Liu, MD,PhD, Heng Li, Huimin Liu, Zengjun Li, MD, PhD, Dehui Zou, MD, Mu Hao, MD, PhD, Lugui Qiu, MD

Blood (2016) 128 (22): 1808.

https://doi.org/10.1182/blood.V128.22.1808.1808

Published: 2016

Journal Articles

The Investigation of Hepatitis Virus Infection in Different Subtypes of B-Cell Non Hodgkin Lymphoma in China: High Infection of Both HBV and HCV in Splenic Marginal Lymphoma

Wenjie Xiong, Shuhua Yi, MD, PhD, Heng Li, Zengjun Li, MD, PhD, Rui Lv, MD, PhD, Wei Liu, MD, PhD, Yan Xu, MD PhD, Dehui Zou, MD, Lugui Qiu, MD

Blood (2016) 128 (22): 5314.

https://doi.org/10.1182/blood.V128.22.5314.5314

Published: 2016

Journal Articles

The Addition of Novel Agents to Front-Line Therapy Significantly Improve the Short-Term and Long-Term Therapeutic Effects of High Risk Waldenstrom's Macroglobulinemia Patients in China

Wenjie Xiong, Shuhua Yi, MD, PhD, Heng Li, Zengjun Li, MD, PhD, Rui Lv, MD, PhD, Wei Liu, MD, PhD, Yan Xu, MD, PhD, Dehui Zou, MD, Mu Hao, MD, PhD, Lugui Qiu, MD

Blood (2016) 128 (22): 5333.

https://doi.org/10.1182/blood.V128.22.5333.5333

Published: 2016

Journal Articles

The Clinical Features and Prognosis of Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia: A Large Series Analysis from a Single Center

Wenjie Xiong, Shuhua Yi, MD, PhD, Heng Li, Zengjun Li, MD, PhD, Rui Lv, MD, PhD, Wei Liu, MD, PhD, Yan Xu, MD, PhD, Dehui Zou, MD, Mu Hao, MD, PhD, Lugui Qiu, MD

Blood (2016) 128 (22): 5334.

https://doi.org/10.1182/blood.V128.22.5334.5334

Published: 2016

Journal Articles

Prognostic Significance of Serum LDH in B Cell Chronic Lymphoproliferative Disorders: A Single-Institution Study of 829 Cases in China

Huimin Liu, Wenjie Xiong, Heng Li, Rui Lv, MD, PhD, Wei Liu, MD, PhD, Shuhua Yi, MD, PhD, Zengjun Li, MD, PhD, Lugui Qiu, MD

Blood (2016) 128 (22): 5336.

https://doi.org/10.1182/blood.V128.22.5336.5336

Published: 2016

Journal Articles

Human Transcription Factor KLF3 Maintains T Lymphocyte Quiescent Phenotype Via Inhibiting SHP-1 Expression

Fang Fang, Mangju Wang, MD, Quan Qiu, Dingfang Bu, Wei Liu, MD, Ying Zhang, Yongjin Shi, Xuzhen Lv, Ping Zhu, MD

Blood (2015) 126 (23): 3426.

https://doi.org/10.1182/blood.V126.23.3426.3426

Published: 2015

Journal Articles

Preclinical Evaluation of the Oral Proteasome Inhibitor Ixazomib in Diffuse Large B-Cell Lymphoma

Wei Liu, MD, Archie Tamayo, MS, Juan Chen, PhD, Shimin Hu, PhD MD, Richard J. Ford, Jr., MD PhD, Lan Pham, PhD

Blood (2015) 126 (23): 4003.

https://doi.org/10.1182/blood.V126.23.4003.4003

Published: 2015

Journal Articles

Association Of Chemokine Receptor CCR5, CCR6 and CCR7 Expressions On T Lymphocyte Subsets In Recipients After Allo-HSCT With Acute GvHD

Meng Wang, MD, Han-Yun Ren, Yu-Jun Dong, MD, Ze-Yin Liang, MD, Zhi-Xiang Qiu, MD, Wei Liu, MD&PhD, Li-Hong Wang, MD

Blood (2013) 122 (21): 4596.

https://doi.org/10.1182/blood.V122.21.4596.4596

Published: 2013

Journal Articles

Maintenance Of Bone Marrow Residency and Self-Renewal Of Leukemic Stem Cells By Cdc42 Gtpase

Benjamin Mizukawa, MD, Eric O'Brien, BS, Wei Liu, MD, PhD, Daniel Moriera Ridsdale, MD, Mark Wunderlich, MS, Yi Zheng, PhD, James C. Mulloy, PhD

Blood (2013) 122 (21): 2889.

https://doi.org/10.1182/blood.V122.21.2889.2889

Published: 2013

Journal Articles

Differential Regulation Of Chemokine Receptor Expressions On T Lymphocyte Subsets In Healthy Donors After Mobilization With Rhg-CSF and Its Correlation With Acute GvHD

Han-Yun Ren, Meng Wang, MD, Xiang-Juan Ma, MD, Yu-Jun Dong, MD, Zhi-Xiang Qiu, MD, Wei Liu, MD&PhD

Blood (2013) 122 (21): 3296.

https://doi.org/10.1182/blood.V122.21.3296.3296

Published: 2013

Journal Articles

Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates The Severity Of Idiopathic Pneumonia Syndrome In a Murine Bone Marrow Transplantation Model

Shukai Qiao, MD, Hanyun Ren, Yongjin Shi, MD, Wei Liu, MD&PhD, Jing Yuan, MD

Blood (2013) 122 (21): 4466.

https://doi.org/10.1182/blood.V122.21.4466.4466

Published: 2013

Journal Articles

A Novel Method of Mobilizing Leukemia Initiating Cells by a Small Molecule Cdc42 Activity-Specific Inhibitor (CASIN) for Acute Myeloid Leukemia Therapy.

Wei Liu, MD, MS, Benjamin Mizukawa, MD, Mark Wunderlich, MS, James F Johnson, James C. Mulloy, PhD, Yi Zheng, PhD

Blood (2009) 114 (22): 13.

https://doi.org/10.1182/blood.V114.22.13.13

Published: 2009

Journal Articles

Role of mTOR in Hematopoiesis and Hematopoietic Stem Cell Regulation.

Fukun Guo, PhD, Wei Liu, MD, MS, Kankana Chava, Jose Cancelas, MD, PhD, George Thomas, Sara C Kozma, PhD, Yi Zheng, PhD

Blood (2009) 114 (22): 1490.

https://doi.org/10.1182/blood.V114.22.1490.1490

Published: 2009

Journal Articles

Mobilization of Hematopoitic Stem/Progenitor Cells by a Cdc42 Activity-Specific Inhibitor

Wei Liu, MD, MS, Lei Wang, PhD, Xun Shang, PhD, Fukun Guo, PhD, Marnie A. Ryan, PhD, Hartmut Geiger, PhD, Yi Zheng, PhD

Blood (2008) 112 (11): 68.

https://doi.org/10.1182/blood.V112.11.68.68

Published: 2008

Journal Articles

Pharmacological Inhibition of EGFR Signaling Enhances G-CSF Induced Hematopoietic Stem Cell Mobilization.

Marnie A. Ryan, PhD, Ellen Xing, David Schleimer, Kalpana Nattamai, Deidre Daria, Wei Liu, MD, MS, Michael Jansen, MS, PhD, Nancy Ratner, Timothy Le Cras, Gary Van Zant, PhD, Yi Zheng, PhD, Hartmut Geiger, PhD

Blood (2008) 112 (11): 2337.

https://doi.org/10.1182/blood.V112.11.2337.2337

Published: 2008

Journal Articles

Decreased Proliferation of Myeloid Leukemia Cells through Down-Regulating LYL1 Expression with Small Interference RNA.

Yuesheng Meng, MD, PhD, Wei Liu, MD, Xiaoxia Ma, MD, Xiuqin Meng, MD, Gongwen Ai, MD, Yanxiang Zhang, MD

Blood (2007) 110 (11): 4158.

https://doi.org/10.1182/blood.V110.11.4158.4158

Published: 2007

NARROW

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Novel MEIS1-FOXO1 Fusion Gene in a Case of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

A Novel Hierarchical Prognostic Model Based on Clinical Feature and Cytogenetics for Splenic Marginal Zone Lymphoma

The Investigation of Hepatitis Virus Infection in Different Subtypes of B-Cell Non Hodgkin Lymphoma in China: High Infection of Both HBV and HCV in Splenic Marginal Lymphoma

The Addition of Novel Agents to Front-Line Therapy Significantly Improve the Short-Term and Long-Term Therapeutic Effects of High Risk Waldenstrom's Macroglobulinemia Patients in China

The Clinical Features and Prognosis of Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia: A Large Series Analysis from a Single Center

Prognostic Significance of Serum LDH in B Cell Chronic Lymphoproliferative Disorders: A Single-Institution Study of 829 Cases in China

Human Transcription Factor KLF3 Maintains T Lymphocyte Quiescent Phenotype Via Inhibiting SHP-1 Expression

Preclinical Evaluation of the Oral Proteasome Inhibitor Ixazomib in Diffuse Large B-Cell Lymphoma

Association Of Chemokine Receptor CCR5, CCR6 and CCR7 Expressions On T Lymphocyte Subsets In Recipients After Allo-HSCT With Acute GvHD

Maintenance Of Bone Marrow Residency and Self-Renewal Of Leukemic Stem Cells By Cdc42 Gtpase

Differential Regulation Of Chemokine Receptor Expressions On T Lymphocyte Subsets In Healthy Donors After Mobilization With Rhg-CSF and Its Correlation With Acute GvHD

Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates The Severity Of Idiopathic Pneumonia Syndrome In a Murine Bone Marrow Transplantation Model

A Novel Method of Mobilizing Leukemia Initiating Cells by a Small Molecule Cdc42 Activity-Specific Inhibitor (CASIN) for Acute Myeloid Leukemia Therapy.

Role of mTOR in Hematopoiesis and Hematopoietic Stem Cell Regulation.

Mobilization of Hematopoitic Stem/Progenitor Cells by a Cdc42 Activity-Specific Inhibitor

Pharmacological Inhibition of EGFR Signaling Enhances G-CSF Induced Hematopoietic Stem Cell Mobilization.

Decreased Proliferation of Myeloid Leukemia Cells through Down-Regulating LYL1 Expression with Small Interference RNA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only